Abstract:Proper and functional immune response requires a complex interaction between innate and adaptive immune cells, which dendritic cells (DCs) are the primary actors in this coordination as professional antigen-presenting cells. DCs are armed with numerous pattern recognition receptors (PRRs) such as nucleotide-binding and oligomerization domain-like receptors (NLRs) like NLRP3, which influence the development of their activation state upon sensation of ligands. NLRP3 is a crucial component of the immune system for protection against tumors and infectious agents, because its activation leads to the assembly of inflammasomes that cause the formation of active caspase-1 and stimulate the maturation and release of proinflammatory cytokines. But, when NLRP3 becomes overactivated, it plays a pathogenic role in the progression of several autoimmune disorders. So, NLRP3 activation is strictly regulated by diverse signaling pathways that are mentioned in detail in this review. Furthermore, the role of NLRP3 in all of the diverse immune cells' subsets is briefly mentioned in this study because NLRP3 plays a pivotal role in modulating other immune cells which are accompanied by DCs' responses and subsequently influence differentiation of T cells to diverse T helper subsets and even impact on cytotoxic CD8 + T cells' responses. This review sheds light on the functional and therapeutic role of NLRP3 in DCs and its contribution to the occurrence and progression of autoimmune disorders, prevention of diverse tumors' development, and recognition and annihilation of various infectious agents. Furthermore, we highlight NLRP3 targeting potential for improving DC-based immunotherapeutic approaches, to be used for the benefit of patients suffering from these disorders.

Unmasking the NLRP3 inflammasome in dendritic cells as a potential therapeutic target for autoimmunity, cancer, and infectious conditions

NLRP3: A promising therapeutic target for autoimmune diseases

NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target

The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers

NLRP3 inflammasome and its inhibitors: a review

The NLRP3 inflammasome: contributions to inflammation-related diseases

Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy

Role of the NLRP3 inflammasome in autoimmune diseases

NLRP3 inflammasome in cancer and metabolic diseases

New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases

Role of NLRP3 inflammasome in central nervous system diseases

NLRP3 Inflammasome and Inflammatory Diseases

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases

NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword

NLRP3 Negative Regulation Mechanisms in the Resting State and Its Implications for Therapeutic Development

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders